Coiffier B et al. A Phase 3 trial comparing bortezomib plus rituximab with rituximab alone in patients with relapsed, rituximab-naïve or -sensitive, follicular lymphoma. Proc ASH 2010;Abstract 857.

Sacchi S et al. Phase II study of Velcade^® plus Mabthera^® in relapsed follicular lymphomas. Proc ASH 2010;Abstract 1801.

Dr Cheson is Professor of Medicine, Head of Hematology and Director of Hematology Research at Georgetown University Hospital’s Lombardi Comprehensive Cancer Center in Washington, DC.